Zatlačte dolů Skála Hodně pěkného dobra imp3 marker Mentalita Rušit Mnich
The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB | eLife
Combinatorial recognition of clustered RNA elements by the multidomain RNA-binding protein IMP3 | Nature Communications
Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis | BMC Gastroenterology | Full Text
Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis | BMC Gastroenterology | Full Text
Cancers | Free Full-Text | IMP3 Protein Overexpression Is Linked to Unfavorable Outcome in Laryngeal Squamous Cell Carcinoma
IMP3 Expression in Thyroid Cancers and its Relationship with Prognostic Parameters
IMP3 and p16 expression in squamous cell carcinoma of the head and neck: A comparative immunohistochemical analysis
Cancers | Free Full-Text | IMP3 Protein Overexpression Is Linked to Unfavorable Outcome in Laryngeal Squamous Cell Carcinoma
USE OF IMP3 AS A PROGNOSTIC MARKER FOR CANCER - diagram, schematic, and image 03
The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB | eLife
The Oncofetal Protein IMP3: A Useful Marker to Predict Poor Clinical Outcome in Neuroendocrine Tumors of the Lung - ScienceDirect
Pathology Outlines - IMP3
Identification Marker Plates, Nylon Tags, and Plastic ID Flags
IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues
IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
A) The location of IMP3 by FISH on DAPI stained human lymphocyte... | Download Scientific Diagram
C-TRAY MARKER-HQ IMP2+IMP3+IMP4 - Rapid Supply
Expression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms
IGF2BP3 (IMP3) expression in angiosarcoma, epithelioid hemangioendothelioma, and benign vascular lesions | Diagnostic Pathology | Full Text
IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16INK4a expression | Modern Pathology